Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

ABSTRACT: RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

PROVIDER: PRJNA1090082 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28401200_1.fastq.gz	Fastqsanger.gz
	SRR28401200_2.fastq.gz	Fastqsanger.gz
	SRR28401300_1.fastq.gz	Fastqsanger.gz
	SRR28401300_2.fastq.gz	Fastqsanger.gz
	SRR28401201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 338

Similar Datasets

RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

Project description:F2 female mice were generated from a cross of two collaborative cross (CC) strains, CC011 x CC074. These mice were infected with Ebola virus and liver samples were prepared at day three after infection. RNA from the livers were prepared and subjected to RNAseq analysis. This data set can be combined with data from GSE165142, in which female mice from the same cross were infected with Ebola virus, and liver samples were prepared at day six after infection. Results: Variations in gene expression levels that may be perdictive for severity

2022-08-31 | GSE173914 | GEO

RNAseq analysis of CC F2 female mice after infection with Ebola virus

Project description:RNAseq analysis of CC F2 female mice after infection with Ebola virus

| PRJNA693338 | ENA

Ebola virus

Project description:Ebola virus Genome sequencing

| PRJNA379115 | ENA

Ebola virus

Project description:Ebola virus Genome sequencing

| PRJNA353605 | ENA

Ebola virus

Project description:Ebola virus Genome sequencing

| PRJNA360286 | ENA

RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

Project description:Gene expression changes in the liver was studied by RNAseq Results: Strong differences in the liver-specific responses between CC011 and CC074 mice

2024-04-17 | GSE262041 | GEO

Immune parameters and outcome during Ebola virus disease

Project description:Immune patterns in Ebola patients were characterized depending on the outcome of the illness. Non-healthy controls were compared to Ebola patients to define the specificity of the immune response against Ebola virus infection.

2019-05-09 | GSE122692 | GEO

RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

Project description:RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

| PRJNA727545 | ENA

Ebola virus

Project description:Ebola virus Genome sequencing and assembly - Liberia, April 2016

| PRJNA344916 | ENA

Plasma proteomic, human Ebola virus disease

Project description:The 2013-2016 Ebola Zaire virus (EBV) outbreak in West Africa resulted in over 28,000 cases and 11,000 deaths. Ebola virus disease (EVD) is a highly virulent systemic disease with a high case fatality rate of ~ 50%. EVD results in hemorrhagic fever marked by an exaggerated systemic inflammatory response, and impaired vascular and coagulation systems. The immune response of patients who either survived or died is characterized by strong differences. Notably, fatalities showed a diminished capacity to mount an appropriate immune response, resulting in high viremia and increased pro-inflammatory cytokine production. In this study, we analyzed 38 sequential samples collected from 12 patients: 8 survivors and 4 fatalities. Our analytical strategy combined three protein-based platforms covering three different fractions of the plasma proteome: the undepleted classical plasma proteome, the depleted plasma proteome, and cytokines/chemokines, using LC/MS- and antibody-based assays, resulting in over 1000 quantified host and pathogen proteins. For depletion of the most abundant plasma proteins, we advanced a perchloric acid-based precipitation method. This method is low cost, high-throughput and robust.

2022-03-29 | PXD030260 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data